Debt-to-equity of MERRIMACK PHARMACEUTICALS INC from 30 Jun 2013 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
MERRIMACK PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 30 Jun 2013 to 31 Mar 2024.
  • MERRIMACK PHARMACEUTICALS INC Debt-to-equity for the quarter ending 31 Mar 2024 was 8.6%, a 190% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2024 8.6% +5.7% +190% 31 Mar 2024
Q4 2023 2.4% -1% -30% 31 Dec 2023
Q3 2023 2.6% -1.1% -30% 30 Sep 2023
Q2 2023 2.7% -1.3% -32% 30 Jun 2023
Q1 2023 3% -1.5% -33% 31 Mar 2023
Q4 2022 3.4% -1.1% -25% 31 Dec 2022
Q3 2022 3.7% -1.1% -23% 30 Sep 2022
Q2 2022 4% -3% -43% 30 Jun 2022
Q1 2022 4.4% -4.7% -51% 31 Mar 2022
Q4 2021 4.5% -8.1% -64% 31 Dec 2021
Q3 2021 4.7% -11% -69% 30 Sep 2021
Q2 2021 7% -11% -61% 30 Jun 2021
Q1 2021 9.1% -7.4% -45% 31 Mar 2021
Q4 2020 13% -17% -58% 31 Dec 2020
Q3 2020 15% -23% -60% 30 Sep 2020
Q2 2020 18% -27% -60% 30 Jun 2020
Q1 2020 17% -30% -64% 31 Mar 2020
Q4 2019 30% -8.5% -22% 31 Dec 2019
Q3 2019 39% +7.8% +25% 30 Sep 2019
Q2 2019 45% +4.1% +10% 30 Jun 2019
Q1 2019 46% -13% -22% 31 Mar 2019
Q4 2018 38% -1414% -97% 31 Dec 2018
Q3 2018 31% +314% 30 Sep 2018
Q2 2018 41% +216% 30 Jun 2018
Q1 2018 60% +204% 31 Mar 2018
Q4 2017 1453% +1613% 31 Dec 2017
Q3 2017 -283% -99% -54% 30 Sep 2017
Q2 2017 -175% +16% +8.4% 30 Jun 2017
Q1 2017 -144% +48% +25% 31 Mar 2017
Q4 2016 -161% +34% +18% 31 Dec 2016
Q3 2016 -184% +11% +5.8% 30 Sep 2016
Q2 2016 -191% +31% +14% 30 Jun 2016
Q1 2016 -193% +55% +22% 31 Mar 2016
Q4 2015 -195% +91% +32% 31 Dec 2015
Q3 2015 -195% +141% +42% 30 Sep 2015
Q2 2015 -222% +229% +51% 30 Jun 2015
Q1 2015 -248% +227% +48% 31 Mar 2015
Q4 2014 -286% +249% +47% 31 Dec 2014
Q3 2014 -336% +303% +47% 30 Sep 2014
Q2 2014 -451% +253% +36% 30 Jun 2014
Q1 2014 -475% 31 Mar 2014
Q4 2013 -535% 31 Dec 2013
Q3 2013 -639% 30 Sep 2013
Q2 2013 -704% 30 Jun 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.